Literature DB >> 26200329

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.

Andrew Blitzer, Mitchell F Brin, Celia F Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26200329     DOI： 10.1002/lary.25273

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  9 in total

1.  Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Vahram Gamsarian; Jane Lee; Vishnutheert Kulkarni; C Gaelyn Garrett; David O Francis
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

2.  A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.

Authors:  Samantha Guiry; Alexis Worthley; Kristina Simonyan
Journal:  Laryngoscope       Date:  2018-12-24       Impact factor: 3.325

Review 3.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

4.  Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Zaki A Ahmed; Simone C Gruber; Jordan S Akins; C Gaelyn Garrett; David O Francis
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

5.  Auditory-Perceptual Evaluation of Deep Brain Stimulation on Voice and Speech in Patients With Dystonia.

Authors:  Mary E Finger; Mustafa S Siddiqui; Amy K Morris; Kathryn W Ruckart; S Carter Wright; Ihtsham U Haq; Lyndsay L Madden
Journal:  J Voice       Date:  2019-03-14       Impact factor: 2.009

Review 6.  The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.

Authors:  Maja Rogić Vidaković; Ivana Gunjača; Josipa Bukić; Vana Košta; Joško Šoda; Ivan Konstantinović; Braco Bošković; Irena Bilić; Nikolina Režić Mužinić
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

Review 7.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

Review 8.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

9.  Classification of vocal tremor using updated consensus-based tremor classification criteria.

Authors:  Vanessa Torrecillas; Kaitlyn Dwenger; Julie M Barkmeier-Kraemer
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.